Catalyst Capital Advisors LLC Biogen Inc. Transaction History

Catalyst Capital Advisors LLC

$4.41 Billion
Q3 2024

A detailed history of Catalyst Capital Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Catalyst Capital Advisors LLC holds 599 shares of BIIB stock, worth $90,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares

599

Previous 142 321.83%

Holding current value

$90,233

Previous $32,000 262.5%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$189.07 - $236.8 $86,404 - $108,217	457 Added 321.83%	599 $116,000
Q2 2024 Jul 25, 2024	BUY	$190.52 - $236.72 $762 - $946	4 Added 2.9%	142 $32,000
Q1 2024 Apr 24, 2024	BUY	$212.02 - $267.71 $29,258 - $36,943	138 New	138 $29,000
Q3 2023 Nov 09, 2023	BUY	$253.3 - $285.89 $6,839 - $7,719	27 Added 33.75%	107 $27,000
Q2 2023 Aug 08, 2023	SELL	$275.25 - $318.06 $1,101 - $1,272	-4 Reduced 4.76%	80 $22,000
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $7,183 - $8,185	-28 Reduced 25.0%	84 $23,000
Q4 2022 Feb 07, 2023	SELL	$252.44 - $306.72 $1,009 - $1,226	-4 Reduced 3.45%	112 $31,000
Q3 2022 Nov 08, 2022	SELL	$194.69 - $268.46 $194 - $268	-1 Reduced 0.85%	116 $31,000
Q2 2022 Aug 09, 2022	BUY	$187.54 - $223.02 $3,000 - $3,568	16 Added 15.84%	117 $24,000
Q1 2022 May 10, 2022	BUY	$193.77 - $244.14 $3,681 - $4,638	19 Added 23.17%	101 $21,000
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $1,791 - $2,302	-8 Reduced 8.89%	82 $20,000
Q3 2021 Nov 09, 2021	SELL	$282.99 - $369.05 $848 - $1,107	-3 Reduced 3.23%	90 $25,000
Q2 2021 Aug 06, 2021	BUY	$259.0 - $414.71 $777 - $1,244	3 Added 3.33%	93 $32,000
Q1 2021 May 10, 2021	SELL	$242.95 - $284.63 $155,002 - $181,593	-638 Reduced 87.64%	90 $25,000
Q4 2020 Feb 05, 2021	SELL	$236.26 - $355.63 $85,526 - $128,738	-362 Reduced 33.21%	728 $178,000
Q3 2020 Nov 05, 2020	SELL	$264.77 - $305.71 $51,630 - $59,613	-195 Reduced 15.18%	1,090 $309,000
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $71,245 - $90,375	-265 Reduced 17.1%	1,285 $407,000
Q4 2019 Feb 06, 2020	BUY	$220.06 - $304.07 $341,093 - $471,308	1,550 New	1,550 $460,000
Q2 2019 Aug 08, 2019	SELL	$219.29 - $241.72 $822,337 - $906,450	-3,750 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$216.71 - $338.96 $812,662 - $1.27 Million	3,750 New	3,750 $886,000
Q4 2018 Feb 07, 2019	SELL	$278.5 - $352.75 $584,850 - $740,775	-2,100 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$293.51 - $383.83 $616,371 - $806,043	2,100 New	2,100 $742,000

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Capital Advisors LLC with notifications on news.

Account

Catalyst Capital Advisors LLC Biogen Inc. Transaction History